摘要
虽然可以产前诊断唐氏综合征(DS),但目前仍无有效的治疗方法来减轻此病的特征性的智力残疾(ID)。而且,早在DS患者的第三个10年间,开始表现出阿尔茨海默病(AD)的病理学特征与继之而来的痴呆, 给他们的家庭和整个社会增加大量的情感和经济负担。从DS染色体三体小鼠模型的研究中显示是对母亲妊娠期和哺乳期膳食补充额外的胆碱是一种潜在的治疗策略。研究表明,母体的胆碱补充(MCS)明显提高DS的Ts65Dn小鼠模型的空间认知和注意力的功能,使成年海马神经形成正常化和提供保护基底前脑胆碱能神经元(BFCNs)在。对神经形成和胆碱能神经元的影响与空间认知显著相关,提示其间的功能关系。本篇综述里,我们强调了这些令人振奋的发现结果,建议在母亲膳食上补充额外的胆碱可以作为一种有效和安全的产前策略,即提高唐氏(DS)患者认知功能、情感表达和神经功能的作用。越来越多的证据表明,增加母亲的胆碱的摄入量会让整个孕期受益,此类建议应该适用于所有怀孕的妇女,从而为唐氏患者,包括患儿以及未察觉到怀有唐氏胎儿的母亲们提供了一个非常早期的干预措施。
关键词: Attention
Current Alzheimer Research
Title:Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease
Volume: 13 Issue: 1
Author(s): Barbara J. Strupp, Brian E. Powers, Ramon Velazquez, Jessica A. Ash, Christy M. Kelley, Melissa J. Alldred and Myla Strawderman, Marie A. Caudill, Elliott J. Mufson and Stephen D. Ginsberg
Affiliation:
关键词: Attention
摘要: Although Down syndrome (DS) can be diagnosed prenatally, currently there are no effective treatments to lessen the intellectual disability (ID) which is a hallmark of this disorder. Furthermore, starting as early as the third decade of life, DS individuals exhibit the neuropathological hallmarks of Alzheimer’s disease (AD) with subsequent dementia, adding substantial emotional and financial burden to their families and society at large. A potential therapeutic strategy emerging from the study of trisomic mouse models of DS is to supplement the maternal diet with additional choline during pregnancy and lactation. Studies demonstrate that maternal choline supplementation (MCS) markedly improves spatial cognition and attentional function, as well as normalizes adult hippocampal neurogenesis and offers protection to basal forebrain cholinergic neurons (BFCNs) in the Ts65Dn mouse model of DS. These effects on neurogenesis and BFCNs correlate significantly with spatial cognition, suggesting functional relationships. In this review, we highlight some of these provocative findings, which suggest that supplementing the maternal diet with additional choline may serve as an effective and safe prenatal strategy for improving cognitive, affective, and neural functioning in DS. In light of growing evidence that all pregnancies would benefit from increased maternal choline intake, this type of recommendation could be given to all pregnant women, thereby providing a very early intervention for individuals with DS, and include babies born to mothers unaware that they are carrying a fetus with DS.
Export Options
About this article
Cite this article as:
Barbara J. Strupp, Brian E. Powers, Ramon Velazquez, Jessica A. Ash, Christy M. Kelley, Melissa J. Alldred and Myla Strawderman, Marie A. Caudill, Elliott J. Mufson and Stephen D. Ginsberg , Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease, Current Alzheimer Research 2016; 13 (1) . https://dx.doi.org/10.2174/1567205012666150921100311
DOI https://dx.doi.org/10.2174/1567205012666150921100311 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Members of CRF Family and their Receptors: From Past to Future
Current Medicinal Chemistry Molecular Foundations for Personalized Therapy in Prostate Cancer
Current Drug Targets The Role of Iron Chelation in Cancer Therapy
Current Medicinal Chemistry Histopathology Image Analysis and Classification Using ARMA Models: Application to Brain Cancer Detection
Current Medical Imaging Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Current Medicinal Chemistry New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence
Current Signal Transduction Therapy Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis
CNS & Neurological Disorders - Drug Targets Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology Opioid Regulation of Mu Receptor Internalisation: Relevance to the Development of Tolerance and Dependence
CNS & Neurological Disorders - Drug Targets Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
Current Pharmaceutical Design Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Current Drug Targets Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Current Cancer Drug Targets Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
Current Neuropharmacology Regulatory Role of Anesthetics on Heme Oxygenase-1
Current Drug Targets Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Role of Acetylcholinesterase Inhibitors in the Metabolism of Amyloid Precursor Protein
Current Drug Targets - CNS & Neurological Disorders